Cyril Ronco

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

ChemMedChem

Cells

ACS medicinal chemistry letters

Beilstein journal of organic chemistry

Université Côte d'Azur

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université Côte d'Azur

France

Associate Professor

Publications

Oleksandr Grytsai, Maeva Dufies, Julie Le Du, Olivia Rastoin, Leticia Christina Pires Gonçalves, Lou Mateo, Sandra Lacas-Gervais, Yihai Cao, Luc Demange, Gilles Pagès, Rachid Benhida, Cyril Ronco
A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR + CXCL-CXCR1/2 Pathway Inhibitor. ACS medicinal chemistry letters 15 (6) (2024)
Oleksandr Grytsai, Nedra Hamouda-Tekaya, Thomas Botton, Stéphane Rocchi, Rachid Benhida, Cyril Ronco
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening. ChemMedChem 19 (3) (2024)
Oleksandr Grytsai, Maeva Dufies, Julie Le Du, Olivia Rastoin, Leticia Christina Pires Gonçalves, Lou Mateo, Sandra Lacas-Gervais, Yihai Cao, Luc Demange, Gilles Pagès, Rachid Benhida, Cyril Ronco
A Potent Solution for Tumor Growth and Angiogenesis Suppression via an ELR + CXCL-CXCR1/2 Pathway Inhibitor. ACS medicinal chemistry letters 15 (6) (2024)
Oleksandr Grytsai, Nedra Hamouda-Tekaya, Thomas Botton, Stéphane Rocchi, Rachid Benhida, Cyril Ronco
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening. ChemMedChem 19 (3) (2024)
Oleksandr Grytsai, Nedra Hamouda-Tekaya, Thomas Botton, Stéphane Rocchi, Rachid Benhida, Cyril Ronco
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening. ChemMedChem 19 (3) (2024)
Oleksandr Grytsai, Nedra Hamouda-Tekaya, Thomas Botton, Stéphane Rocchi, Rachid Benhida, Cyril Ronco
Design, Synthesis and Biological Evaluation of Novel Anticancer Amidinourea Analogues via Unexpected 1,3,5-Triazin-2-one Ring Opening. ChemMedChem (2023)
Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida, Sonia Martial, Gilles Pagès
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells 11 (23) (2022)
Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida, Sonia Martial, Gilles Pagès
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells 11 (23) (2022)
Marie Fabre, Lou Mateo, Diana Lamaa, Stephanie Baillif, Gilles Pagès, Luc Demange, Cyril Ronco, Rachid Benhida
Recent Advances in Age-Related Macular Degeneration Therapies. Molecules (Basel, Switzerland) 27 (16) (2022)
Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida, Sonia Martial, Gilles Pagès
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells 11 (23) (2022)
Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida, Sonia Martial, Gilles Pagès
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells 11 (23) (2022)
Manon Penco-Campillo, Clément Molina, Patricia Piris, Nouha Soufi, Manon Carré, Marina Pagnuzzi-Boncompagni, Vincent Picco, Maeva Dufies, Cyril Ronco, Rachid Benhida, Sonia Martial, Gilles Pagès
Targeting of the ELR+CXCL/CXCR1/2 Pathway Is a Relevant Strategy for the Treatment of Paediatric Medulloblastomas. Cells 11 (23) (2022)
Oleksandr Grytsai, Cyril Ronco, Rachid Benhida
Synthetic accesses to biguanide compounds. Beilstein journal of organic chemistry 17 (2021)
Antoine Millet, Mauro Safir Filho, Nedra Hamouda-Tekaya, Elisa Cavazza, Patricia Abbe, Johanna Rüdiger, Magali Plaisant, Julie Mayen, Stéphane Rocchi, Cyril Ronco, Rachid Benhida
Development and in vivo evaluation of fused benzazole analogs of anti-melanoma agent HA15. Future medicinal chemistry 13 (14) (2021)
Tom Baladi, Nedra Hamouda-Tekaya, Letícia Christina Pires Gonçalves, Stéphane Rocchi, Cyril Ronco, Rachid Benhida
Sulfonylguanidine Derivatives as Potential Antimelanoma Agents. ChemMedChem 15 (13) (2020)

Cyril Ronco.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cyril Ronco